Apr 12, 2022 / 10:30PM GMT
Operator
Good evening, ladies and gentlemen, and thank you for joining the Alpine Immune Sciences 2022 AACR Virtual Investor Event. Currently, all participants are on a listen-only mode. Following management's presentation, we will hold a question-and-answer session with Executive Chairman and Chief Executive Officer, Mitchell Gold; President and Head of Research and Development, Stanford Peng; Chief Business Officer; Remy Durand; and Chief Financial Officer, Paul Rickey. (Operator Instructions) If any investors have questions, please send them to [email protected]. (Operator Instructions)
As a reminder, this event is being recorded today, Tuesday, April 12, 2022.
Mitchell Gold - Alpine Immune Sciences - Executive Chairman & CEO
Thank you, operator. Good afternoon, and good evening. Thank you to all of those in attendance, and welcome to Alpine Immune Sciences Virtual AACR 2022 Data Review. I'm Mitch Gold, the Executive Chairman and CEO of Alpine.
Today marks an important day in our company's history with the full presentation of the dose
Alpine Immune Sciences Inc To Host Virtual Investor Event At 2022 AACR Annual Meeting Transcript
Apr 13, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers